During his eclectic career, Peter has worked in academic research administration, in pharmaceutical industry R&D, and for contract research organizations (CRO). More specifically, he has consulted on both intellectual property issues and scientific questions. His experience has allowed him to develop a wide range of technical and professional skills, which he has channeled into complex projects in the healthcare sector. 

He also received many awards and scholarships during his academic career.

Peter is recognized by his peers as an ambassador of progress in the healthcare sector, leveraging his passion for innovation in the life sciences.

Publications

• Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression. Brain, Behavior and Immunity 99:363-382, 2022
• Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monocytes with Patrolling Properties. Cell Reports 20(8):1830-1843, 2017
• High fat diet exacerbates Alzheimer’s disease-related pathology in APPswe/PS1 mice. Oncotarget, 2016
• Senescence impairs myelin debris clearance. Current biology 16, 772–775, 2016
• Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner. Oncotarget, 2016
• Isolation and purification of murine microglial cells for flow cytometry. Bio-Protocol 6-1, 2016
• Recombinant tissue-plasminogen activator attenuates the development of Alzheimer's disease-related pathology in APPswe/PS1 mice. Neuropsychopharmacology 1-38, 2015
• The dynamics of monocytes and microglia in Alzheimer's disease. Alzheimer's research and therapy 7-41, 2015
• The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders. International Journal of Molecular Sciences, 2014
• Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation. Acta Neuropathologica Communications 1-75, 2013
• Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proceedings of the National Academy of Sciences 110, 1941–1946, 2013
• Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behavioural Brain Research 234, 334–342, 2012